Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma

Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma

<b>Background/Objectives</b>: Hepatocellular carcinoma (HCC) remains a significant global health concern, primarily due to the limited efficacy of targeted therapies, which are often compromised by drug resistance and adverse side effects. <b>Methods</b>: In this study, we ut...

Full description

Saved in:
Bibliographic Details
Main Authors: Hezhou Long, Jiafu Zhou, Changxia Zhou, Shuyu Xie, Jingling Wang, Minjia Tan, Junyu Xu
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biomedicines
Subjects:
proteomics
hepatocellular carcinoma
hepatocellular carcinoma-targeted drugs
S/T/Y phosphorylation
drug combination
Online Access:https://www.mdpi.com/2227-9059/13/1/152
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items